CoreWeave, Discord, Klarna and Jio are among the high-value tech companies on the slate for 2025 IPOs, but market volatility could delay things, says exits expert Jeff Baglio.

From deciding which markets to go into, how many team members to send and whether it is worth taking an LP position in a local VC fund instead, here are six things to think about before opening an overseas office.

With a more-than-$200m fund on the horizon, rEnergy Partners is looking to write big cheques with an eye on profitability.

Hospital CVCs are growing and diversifying to confront the challenges facing the US healthcare system.

Web3 looks set to be responsible for a flurry of exits as buyers take advantage of friendlier regulation and entertainment companies join fintech as key players.

If a venturing unit want to maximise a startup’s chance of scaling its technology in a corporate, it should become a customer, says Cencosud Ventures’ Pascual.

Medtech funding has been one of the fastest growing areas of CVC, and here are some of its brightest startups, from brain surgery microbots to holographic surgery technology.

UK-based Oxa focuses on services in airports, retirement communities and industrial settings, rather than personal cars and taxis.

Mining companies are finding technology in university labs to reduce their greenhouse gas emissions.

AI, connectivity and electrification are changing the customer’s automotive experience, and incumbents must innovate while shepherding them through it to avoid disruption.

The Korean company has been working on the technology for the past four years and plans to launch early in 2026.

Investor interest in self-driving cars is booming again as commercial services have started operating. These are some of the opportunities that are emerging.

Agtech investing has been slow, but new genetics and digital technologies could bring back the big success stories, says Leaps by Bayer’s PJ Amini.

The venture firm is targeting consumer health startups that can prevent illness before it happens and has secured health product maker Schwabe as its financier.